Adiponectin has been shown to counteract the effect of leptin by inhibiting leptin-induced migration and invasion in breast cancer in addition to leptin-induced clonogenicity and anchorage independent cell growth. This evidence concerns the gene ADIPOQ and breast carcinoma.